Inhibitory Effects of Rolipram on Partially Purified Phosphodiesterase 4 From Rat Brains
スポンサーリンク
概要
- 論文の詳細を見る
Several previous studies have demonstrated that the phosphodiesterase 4 selective inhibitor rolipram affects cellular function at a much lower concentration than the reported Ki value for phosphodiesterase 4 inhibition. In this study, we examined the inhibitory effect of rolipram on rat brain phosphodiesterase 4 to determine the heterogeneity of the enzyme activity. Partial purification of various phosphodiesterases from the rat brain was performed by anion-exchange chromatography. The eluant was pooled into four fractions, two of which manifested cAMP-selective phosphodiesterase activity that was blocked by 10 μM of rolipram, indicating the presence of phosphodiesterase 4 in these fractions. The IC50 of rolipram (racemate) of these two fractions was 492 and 79 nM, respectively. The R-(-)-enantiomer of rolipram inhibited the cAMP-phosphodiesterase activity in the latter fraction 10 times more than did S-(+)-rolipram, and the inhibition of the former fraction was less stereospecific. Dixon plot analysis revealed that the rolipram enantiomers inhibited the cAMP-phosphodiesterase in the latter fraction in a multiphasic manner, with two Ki values, one at the micromolar level and the other at the sub-micromolar level, respectively, for both of the enantiomers. These results suggest that there is a heterogeneity for phosphodiesterase 4 in the rat brain, and some of the phosphodiesterase forms are sensitive to rolipram.
- 社団法人 日本薬理学会の論文
- 1998-06-01
著者
-
Ohsawa Fukuichi
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Baba Jun
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd
-
Baba Jun
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Sawa A
Meiji Seika Kaisha Ltd. Yokohama Jpn
-
Sawa Aiko
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd
-
Sawa Aiko
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
YAMAUCHI Miki
Drug Discovery, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
NAGASO Hiroshi
Drug Discovery, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
MURAKAMI Shoichi
Drug Discovery, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
Nagaso Hiroshi
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Yamauchi Miki
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Murakami Shoichi
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
関連論文
- Rolipram, a Phosphodiesterase-4-Selective Inhibitor, Promotes the Survival of Cultured Rat Dopaminergic Neurons
- Rolipram, a Selective Inhibitor of Phosphodiesterase Type 4, Pronouncedly Enhanced the Forskolin-Induced Promotion of Dopamine Biosynthesis in Primary Cultured Rat Mesencephalic Neurons
- Neither the 5-HT_ - nor the 5-HT_2 - Receptor Subtype Mediates the Effect of Fluvoxamine, a Selective Serotonin Reuptake Inhibitor, on Forced - Swimming - Induced Immobility in Mice
- 5-HT_ - Receptor Subtype Mediates the Effect of Fluvoxamine, a Selective Serotonin Reuptake Inhibitor, on Marble - Burying Behavior in Mice
- Inhibitory Effects of Rolipram on Partially Purified Phosphodiesterase 4 From Rat Brains